Beta Bionics, Inc. (BBNX)

Beta Bionics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	605	-	-	-
Enterprise Value	380	-	-	-
Debt / Equity Ratio	0.02	0.10	0.07	0.32
Asset Turnover	-	0.50	0.17	-
Inventory Turnover	-	4.01	-	-
Quick Ratio	14.59	5.47	9.54	3.12
Current Ratio	15.88	6.29	9.77	3.21
Return on Equity (ROE)	-	-81.35%	-123.17%	-
Return on Assets (ROA)	-	-21.78%	-30.79%	-
Return on Capital (ROIC)	-	-38.72%	-56.04%	-
Buyback Yield / Dilution	-150.89%	-20.01%	-6.13%	-

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q